Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: A prospective study

Journal of Pain and Symptom Management

Volumn 12, Issue 3, 1996, Pages 161-167

  Galer, Bradley S ^a   Harle, James ^a   Rowbotham, Michael C ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

lidocaine; mexiletine; neuropathy; Pain

Indexed keywords

LIDOCAINE; LOCAL ANESTHETIC AGENT; MEXILETINE; SODIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; DRUG EFFECT; DRUG RESPONSE; DRUG SCREENING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LOCAL ANESTHESIA; MALE; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PREDICTION; PROSPECTIVE STUDY;

EID: 0030248166     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(96)00126-1     Document Type: Article

References (16)

1. 1. Chabal C, Jacobson L, Mariano A, Chaney E, Britell CW. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992;76:513-517.
2. 2. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic diabetic neuropathy. Lancet 1988;2:9-11.
3. 3. Edwards WT, Habib F, Burney RG, Begin G. Intravenous lidocaine in the management of various chronic pain states - a review of 211 cases. Reg Anesth 1985;10:1-6.
4. 4. Galer BS, Miller KV, Rowbotham MC. Response to intravenous lidocaine differs based on clinical diagnosis and site of nervous system injury. Neurology 1993;43:1233-1235.
5. 5. Kastrup J, Petersen P, Dejgard A, Angelo, HR, Histed J. Intravenous lidocaine infusion - a new treatment of chronic painful diabetic neuropathy? Pain 1987;28:69-75.
6. 6. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41:1024-1028.
7. 7. Tanelian DL, MacIver MB. Analgesic concentrations of lidocaine suppress tonic A-delta and C-fiber discharges produced by acute injury. Anesthesiology 1991;74:934-936.
8. 8. Chabal C, Russell LC, Burchiel KJ. The effect of intravenous lidocaine, tocainide, and raexiletine on spontaneously active fibers in rat sciatic neuromas. Pain 1989;38:333-338.
9. 9. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992;48:261-268.
10. 10. Murray KT, Barbey JT, Kopelman HA, Siddoway A, Echt DS, Woosley R, Roden DM. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing. Clin Pharmacol Ther 1989;45:553-561.
11. 11. Nystrom B, Hagbarth KE. Microelectrode recordings from transected nerves in amputees with phantom limb pain. Neurosci Lett 1981;27:211-216.
12. 12. Rull JA, Quibrera R, Gonzalez-Millan H, Lozano Castaneda O. Symtomatic treatment of peripheral diabetic neuropathy with carbamazepine: double-blind crossover trial. Diabetologia 1969;5:215-218.
13. 13. Tanelian DL, Brose MB. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology 1991;74:949-951.
14. 14. Baranowski AP, De Courcey J, Justings D, Charlton JE, Wall PD, Scadding JW. Postherpetic neuralgia and low dose intravenous lignocaine-preliminary results. In: Proceedings of the Seventh World Congress on Pain. 1993:188.
15. 15. Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 1994;35:S50-S53.
16. 16. Portenoy RK. Continuous intravenous infusion of opioid drugs. Med Clin North Am 1987;71:233-241.